Balanced polymorphism: A survival advantage in celiac disease

Medical Hypotheses

Volumn 77, Issue 1, 2011, Pages 1-2

  Lerner, Aaron ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

CD3+ T LYMPHOCYTE; CELIAC DISEASE; DIETARY INTAKE; EDITORIAL; GENETIC POLYMORPHISM; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPOTHESIS; IMMUNE DEFICIENCY; LIPID DIET; MEAT; NONHUMAN; OBESITY; PREVALENCE; SCANDINAVIA; SURVIVAL;

CELIAC DISEASE; HETEROZYGOTE; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA;

EID: 79958032043     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.04.033     Document Type: Editorial

References (19)

1. Joel D., Bhavesh M. Potential selective advantage mechanism for polymorphic genetics in celiac disease. Med Hypotheses 2011, 77:3-4.
2. Venkatasubramani N., Telega G., Werlin S.L. Obesity in pediatric celiac disease. J Pediatr Gastroenterol Nutr 2010, 51:295-297.
3. Dickey W., Kearney N. Overweight in celiac disease; prevalence, clinical characteristics, and effect of a gluten-free diet. Am J Gastroenterol 2006, 101:2356-2359.
4. lohi S., Maki M., Rissanen H., Knekt P., Reunanen A., Kaukinen K. Prognosis of unrecognized celiac disease as regards mortality: a population-based cohort study. Ann Med 2009, 41:508-515.
5. Ebert E.C. Activation of human intraepithelial lymphocytes reduced CD3 expression. Clin Exp Immunol 2003, 132:424-429.
6. Malamut G., El Machhour R., Montcuquet N., Martin-lanneree S., Dusanter-Fourt I., et al. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J Clin Invest 2010, 120:2131-2143.
7. Ludvigsson J.F., Wahlstrom J., Grunewald J., Ekbom A., Montgomery S.M. Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax 2007, 62:23-28.
8. Ludvigsson J.F., Sanders D.S., Maeurer M., Jonsson J., Grunewald J., et al. Risk of tuberculosis in a large sample of patients with celiac disease - A nationwide cohot study. Aliment Pharmacol Ther 2011, 33:689-696.
9. Barada K., Bitar A., Mokadem M.A., Hashash J.G., Green P. Celiac disease in Middle Eastern and North African countries: a new burden. World J Gastroenterol 2010, 16:1449-1457.
10. Teresi S., Crapisi M., Vallejo M.D., Castellaneta S.P., Francavilla R., et al. Celiac disease seropositivity in Saharawi children: a follow-up and family study. J Pediatr Gastroenterol Nutr 2010, 50:506-509.
11. Cottam D.R., Schaefer P.A., Shaftan G.W., Angus L.D. Dysfunctional immune-privilege in morbid obesity; implication and effect of gastric bypass surgery. Obes Surg 2003, 13:49-57.
12. Cottam D.R., Schaefer P.A., Fahmy D., Shaftan G.W., Angus L.D. The effect of obesity on neutrophil Fc receptors and adhesion molecules (CD16, CD11b, CD62l). Obes Surg 2002, 12:230-235.
13. Mulder S.J., mulder-Bos G.C. Most probable origin of coeliac disease is low immune globulin A in the intestine caused by malfunction of Peyer's patches. Med Hypotheses 2006, 66:757-762.
14. Zanzi D., Stefanile R., Santagata S., Iaffaldano L., Iaquinto G., et al. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in celiac disease. Am J Gastroenterol 2011, [Epub ahead of print].
15. Lerner A., Gruener N., Iancu T.C. Serum carnitine levels in coeliac disease. GUT 1993, 34:933-935.
16. Grainge M.J., West J., Card T.R., Holmes G.K. Causes of death in people with celiac disease spanning the pre-and post-serology era: A population-based cohot study from derby, UK. Am J Gastroenterol 2011, 106:933-939.
17. Lerner A. Factors affecting the clinical presentation and time diagnosis of celiac disease: the Jerusalem and the West Bank-Gaza experience (editorial). Isr J Med Sci 1994, 30:294-295.
18. Lerner A., Blank M., Shoenfeld Y. Celiac disease and autoimmunity. Isr J Med Sci 1996, 32:33-36.
19. Lerner A. New therapeutic strategies for celiac disease. Autoimmun Rev 2010, 9:144-147.